Literature DB >> 16478835

Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department.

Stephen Trzeciak1, R Phillip Dellinger, Nicole L Abate, Robert M Cowan, Mary Stauss, J Hope Kilgannon, Sergio Zanotti, Joseph E Parrillo.   

Abstract

OBJECTIVE: Early goal-directed therapy (EGDT) has been shown to decrease mortality in patients with severe sepsis and septic shock. Consensus guidelines now advocate EGDT for the first 6 h of sepsis resuscitation. However, EGDT has not yet been widely adopted in practice. A need for effective collaboration between emergency medicine and critical care medicine services has been identified as an obstacle for implementation. We aimed to determine if EGDT end points could reliably be achieved in real-world clinical practice.
METHODS: EGDT was implemented as a collaborative emergency medicine/critical care quality improvement initiative. EGDT included the following: i.v. fluids (IVF) targeting central venous pressure > or = 8 mm Hg, vasopressors targeting mean arterial pressure > or = 65 mm Hg, and (if necessary) packed RBCs (PRBCs) and/or dobutamine targeting central venous oxygen saturation > or = 70%. A retrospective analysis was performed of emergency department (ED) patients with persistent sepsis-induced hypotension (systolic BP < 90 mm Hg despite 1.5 L of IVF) treated with EGDT during the first year of the initiative. Primary outcome measures included successful achievement of EGDT end points and time to achievement. A secondary analysis was performed comparing EGDT cases to historical control cases (nonprotocolized control subjects without invasive monitoring).
RESULTS: All end points were achieved in 20 of 22 cases (91%). The median time to reach each end point was < or = 6 h. In the secondary analysis, patients (n = 38; EGDT, n = 22; pre-EGDT, n = 16) had similar age, do-not-resuscitate status, severity scores, hypotension duration, and vasopressor requirement (p = not significant). In the ED, EGDT used more IVF and included PRBC/dobutamine utilization, without any impact on the overall use of these therapies through the first 24 h in the ICU. EGDT was associated with decreased ICU pulmonary artery catheter (PAC) utilization (9.1% vs 43.7%, p = 0.01).
CONCLUSIONS: With effective emergency medicine/critical care collaboration, we demonstrate that EGDT end points can reliably be achieved in real-world sepsis resuscitation. ED-based EGDT appears to decrease ICU PAC utilization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478835     DOI: 10.1378/chest.129.2.225

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  75 in total

1.  [New sepsis guidelines yet again: is that necessary?].

Authors:  R Rossaint
Journal:  Anaesthesist       Date:  2010-04       Impact factor: 1.041

2.  Factors associated with nonadherence to early goal-directed therapy in the ED.

Authors:  Mark E Mikkelsen; David F Gaieski; Munish Goyal; Andrea N Miltiades; Jeffrey C Munson; Jesse M Pines; Barry D Fuchs; Chirag V Shah; Scarlett L Bellamy; Jason D Christie
Journal:  Chest       Date:  2010-02-19       Impact factor: 9.410

3.  Current treatment of severe sepsis.

Authors:  Ismail Cinel; R Phillip Dellinger
Journal:  Curr Infect Dis Rep       Date:  2006-09       Impact factor: 3.725

4.  Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock.

Authors:  Michael A Puskarich; Stephen Trzeciak; Nathan I Shapiro; Alan C Heffner; Jeffrey A Kline; Alan E Jones
Journal:  Resuscitation       Date:  2011-06-23       Impact factor: 5.262

5.  Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock.

Authors:  Alan E Jones; Anne Focht; James M Horton; Jeffrey A Kline
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

6.  Implementing early goal-directed therapy in the emergency setting: the challenges and experiences of translating research innovations into clinical reality in academic and community settings.

Authors:  Alan E Jones; Nathan I Shapiro; Michael Roshon
Journal:  Acad Emerg Med       Date:  2007-07-13       Impact factor: 3.451

7.  Management of septic shock: where do we stand?

Authors:  J Sankar; R Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2009-01-07       Impact factor: 1.967

8.  Costs of intermittent measurement of central venous oxygen saturations by blood gas analysis.

Authors:  Frank Bloos; Florian Rissner; Martin Specht; Konrad Reinhart; Gernot Marx
Journal:  Intensive Care Med       Date:  2009-01-23       Impact factor: 17.440

9.  Liberal Versus Restrictive Intravenous Fluid Therapy for Early Septic Shock: Rationale for a Randomized Trial.

Authors:  Wesley H Self; Matthew W Semler; Rinaldo Bellomo; Samuel M Brown; Bennett P deBoisblanc; Matthew C Exline; Adit A Ginde; Colin K Grissom; David R Janz; Alan E Jones; Kathleen D Liu; Stephen P J Macdonald; Chadwick D Miller; Pauline K Park; Lora A Reineck; Todd W Rice; Jay S Steingrub; Daniel Talmor; Donald M Yealy; Ivor S Douglas; Nathan I Shapiro
Journal:  Ann Emerg Med       Date:  2018-05-10       Impact factor: 5.721

10.  Development and simultaneous application of multiple care protocols in critical care: a multicenter feasibility study.

Authors:  Jukka Takala; R Philip Dellinger; Kati Koskinen; Arthur St Andre; Martyn Read; Mitchell Levy; Stephan M Jakob; Patricia Veiga C Mello; Raymond Friolet; Esko Ruokonen
Journal:  Intensive Care Med       Date:  2008-04-03       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.